Skip to main content
GNMX logo
GNMX
(BATS)
Corgi Genomics & Precision Medicine ETF
$30.12-- (--)
Loading... - Market loading

GNMX ETF: Corgi Genomics & Precision Medicine ETF - Price, Holdings & Analysis

Corgi Genomics & Precision Medicine ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$29.84 - $29.84
52-Week High$32.31
52-Week Low$23.88
Open$29.84
Volume100
Average Volume (3M)437
Expense Ratio0.35%
Total Holdings60
Inception DateMay 5, 2026
1 Day Change-1.54%
1 Month Change8.38%
YTD Change17.96%
50-Day MA$27.73
RSI54.77
Stochastic %K0.00
Stochastic %D12.47
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Corgi Genomics & Precision Medicine ETF

What is the current price of GNMX?

The latest GNMX price is $29.84. The 52-week range is $23.88–$32.31.

What is the expense ratio for GNMX?

GNMX's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does GNMX pay dividends?

Corgi Genomics & Precision Medicine ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.

What are the top holdings of GNMX?

GNMX's largest holdings are Thermo Fisher Scientific Inc. (8.6%), Vertex Pharmaceuticals Incorporated (7.0%), Alnylam Pharmaceuticals, Inc. (4.4%) (combined weight: 20.0%). The fund holds 60 total positions. View the complete portfolio breakdown in the Holdings section.

How does GNMX compare to similar ETFs?

Compare GNMX (0.35% expense ratio) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.